Scientific Advisory Board

Find out how our Scientific Advisory Board guide our research decisions to benefit more women living with ovarian cancer, and those yet to be diagnosed.

The Scientific Advisory Board is a group of expert researchers and clinicians from the UK and Europe. They oversee and advise on Target Ovarian Cancer's research programme.

The Board provides advice on:

  • development of the research strategy and funding programme

  • which project proposals should be invited to make a full application

  • external reviewers for grant applications

  • external peer reviewer and research champion comments on full grant applications

  • make recommendations for research funding to our Board of Trustees

  • annual review of funded projects.

The Scientific Advisory Board must comply with, and declare conflicts of interest in line with, our conflicts of interest policy.

Board members

Professor Ruth Plummer, Professor of Experimental Cancer Medicine at the Northern Institute for Cancer Research, Newcastle University (Chair)

Professor Richard Edmondson, Clinical Professor in Gynaecological Oncology, Manchester University.

Dr Ros Glasspool, Consultant Medical Oncologist and Honorary Clinical Senior Lecturer, University of Glasgow

Professor Maurizio D'Incalci, Laboratory of Cancer Pharmacology, Humanitas Research Hospital, Milan

Dr Rebecca Kristeleit, Consultant Medical Oncologist, Guy's and St Thomas' NHS Foundation Trust

Professor Chris Lord, Deputy Head of Division and Leader of the Gene Function Team at The Institute of Cancer Research, London